# US 2025/0146045 A1 · Methods for determination of bacteria in samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0146045 A1
- Document ID: US20250146045A1
- Status: Published application
- Kind: A1
- Application number: 18/941,160
- Filed: 2024-11-08
- Published: 2025-05-08
- Earliest claimed: 2023-11-08
- Assignees: IDEXX Laboratories, Inc.
- Applicants: IDEXX Laboratories, Inc.
- Inventors: Jeremy Hammond; JuiMing Lin; Julia Chase; Seana Gray; Sarah Roger
- Web page: https://patentgrep.com/patent/US20250146045A1

## CPC

- C12Q 1/06: Quantitative determination
- C12Q 1/04: Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)}
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 21/6458: {Fluorescence microscopy (fluorescence microscopes per se G02B21/0076 and G02B21/16)}
- G01N 2021/6439: {with indicators, stains, dyes, tags, labels, marks}
- G01N 2201/127: Calibration; base line adjustment; drift compensation
- G01N 2333/195: from bacteria
- G01N 2333/24: from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- G01N 2333/245: Escherichia (G)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

An apparatus and method for detecting the type, presence or amount of bacteria in a sample. The apparatus and method involve staining a liquid sample with a fluorescent stain corresponding to bacteria and imaging one or more portions of the sample at a selected set of sample Z-axis heights, X-Y coordinates, or both, within the sample after a predetermined time to allow for non-bacterial components in the sample to settle out of solution. A calibration method for correlating the concentration or amount of bacteria in biological samples by different analysis methods including glass slide methods, agar plate colony culture methods and high precision methods.

## Claims

### Claim 1

A method for detecting a type, presence or amount of bacteria in a liquid comprising:
staining a liquid sample with a fluorescent stain for bacteria,
introducing the stained liquid sample into a sample container having a Z-axis height that allows for settling of components of the liquid sample;
allowing the components in the liquid sample to settle for a predetermined amount of time;
imaging a Z-axis field of view (FOV) comprising an increment of the Z-axis height in the liquid sample at a location comprising an X-axis and Y-axis coordinate (X-Y coordinate); and
determining the presence or absence of bacteria within the FOV and correlating the type, presence or amount of bacteria in the FOV to the type, presence or amount of bacteria in the liquid sample.

### Claim 2 (depends on 1)

The method of claim 1, wherein an image of the FOV is obtained with a confocal microscope or an epifluorescence (EPI) microscope.

### Claim 3 (depends on 1)

The method of claim 1, wherein the imaging comprises obtaining a plurality of FOVs at the X-Y coordinate and correlating the type, presence or amount of bacteria in the plurality of FOVs to the type, presence or amount of bacteria in the liquid sample.

### Claim 4 (depends on 1)

The method of claim 1, wherein the Z-axis height is between about 0.1 to 1 mm.

### Claim 5 (depends on 4)

The method of claim 4, wherein a depth of field of the increment of the Z-axis height is about 1 μm to 10 μm.

### Claim 6 (depends on 1)

The method of claim 1, wherein determining the presence or absence of bacteria within the FOV comprises comparing an image of the FOV to a predetermined image indicative of the presence or type of bacteria in the FOV.

### Claim 7 (depends on 1)

The method of claim 1, wherein the imaging comprises determining a fluorescence spectra of stained bacteria in the FOV.

### Claim 8 (depends on 1)

The method of claim 1, wherein the imaging comprises determining a fluorescence spectra of stained bacteria in the FOV and determining a strain of the bacteria in the FOV based upon the fluorescence spectra.

### Claim 9 (depends on 1)

The method of claim 1, further comprising processing a native human, animal, environmental or industrial sample to obtain the liquid sample by mixing the native sample with a reagent comprising a surfactant and a buffer.

### Claim 10 (depends on 1)

The method of claim 1, wherein the sample is ear cerumen, peripheral blood, a solid tumor, fine needle aspirate, urine or body cavity fluid.

### Claim 11 (depends on 1)

The method of claim 1, further comprising obtaining a bright-field image of the FOV.

### Claim 12 (depends on 1)

The method of claim 1 wherein the determining comprises analyzing an image with a computing device coupled to or in communication with a camera that images a FOV and executes instructions stored in a memory of the computing device.

### Claim 13

A method for calibrating a bacterial detection method, comprising
(a) counting bacteria from a biological sample using a glass slide method to obtain a reference count,
(b) culturing bacteria from a portion of the biological sample on a first plate;
(c) counting the bacteria on the first plate;
(d) collecting a first plate sample from the first plate having a first predetermined quantity of bacteria;
(e) analyzing the first plate sample in a high precision analysis method for determining an amount of bacteria in the first plate sample,
(f) correlating the amount of bacteria determined in step (e) to an amount of bacteria in the plate sample determined in step (c), and
(g) comparing the amount of bacteria in the first plate sample to the amount of bacteria in the reference count.

### Claim 14 (depends on 13)

The method of claim 13, wherein the high precision analysis method comprises:
(i) combining at least a portion of the first plate sample with a fluorescent stain for bacteria to provide an analysis sample,
(ii) introducing the analysis sample into a sample container having a Z-axis height that allows for settling of components of the analysis sample;
(iii) allowing components in the analysis sample to settle for a predetermined amount of time;
(iv) imaging a Z-axis field of view (FOV) comprising an increment of the Z-axis height in the liquid sample at a location comprising plurality of X-axis and Y-axis coordinates (X-Y coordinates); and
(v) determining the amount of bacteria within the FOV.

### Claim 15 (depends on 13)

The method of claim 13, further comprising repeating steps (d) through (g) with a second plate sample comprising a second predetermined quantity of bacteria collected from the first plate or a second plate comprising as second bacteria culture comprising bacteria from the biological sample cultured on a second plate.

### Claim 16 (depends on 13)

The method of claim 13, wherein the first plate sample is diluted prior to step (e).

### Claim 17 (depends on 13)

The method of claim 13, wherein the first predetermined quantity of bacteria is determined by measuring the optical density of the first diluted plate sample.

### Claim 18 (depends on 13)

The method of claim 13, further comprising collecting at least a portion of the first bacteria culture with a swab or a loop, optionally further comprising collecting at least a portion of the second bacteria culture with a swab or a loop.

### Claim 19 (depends on 13)

The method of claim 13, further comprising preparing a transfer function to correlate the amount of the bacteria determined in step (e) to the amount of bacteria in the reference count.

### Claim 20 (depends on 13)

The method of claim 13, wherein the amount of the bacteria measured on the glass slide in step (a) is identified within one of a plurality of defined ranges of quantities of bacteria.

### Claim 21 (depends on 20)

The method of claim 20, wherein the defined ranges are correlated to clinical decision points associated with bacteria in a biological sample and resulting in a diagnosis of infection.

### Claim 22 (depends on 13)

The method of claim 13, wherein the quantity of bacteria measured in step (e) is identified as within one of a plurality of defined ranges of quantities of bacteria.

### Claim 23 (depends on 13)

The method of claim 13, wherein the counting the bacteria on the plate comprises counting colony forming units on the plate.
